Aim: To investigate liver biochemistry in infants screened for biliary atresia (BA) at the time of hepatobiliary scintigraphy (HS) and to evaluate the effect of change in threshold for HS.
Methods: Infants born from 2010 to 2021, who underwent HS <6 months postpartum for BA, were included and data sourced from electronic medical records. The change in threshold in 2018 from ≥20 (and/or if conjugated bilirubin exceeds 20% of total bilirubin) to ≥17 μM (regardless of total bilirubin) was evaluated.
Aim: Indocyanine green (ICG) clearance, a sensitive biomarker for liver function, has not been validated in children. We assessed the association between ICG clearance and liver function in children with liver disease.
Methods: ICG plasma disappearance rate (ICG-PDR, %/min) was measured in children with liver disease.
BMJ Open
November 2024
Purpose: The Management of Post-transplant Infections in Collaborating Hospitals (MATCH) programme, initiated in 2011 and still ongoing, was created to 1) optimise the implementation of existing preventive strategies against viral infections in solid organ transplant (SOT) recipients and allogenic haematopoietic stem-cell transplant (HSCT) recipients and 2) advance research in the field of transplantation by collecting data from a multitude of sources.
Participants: All SOT and HSCT recipients at Copenhagen University Hospital, Rigshospitalet, are followed in MATCH. By February 2021, a total of 1192 HSCT recipients and 2039 SOT recipients have been included.
While mercury occurs naturally in the environment, human activity has significantly disturbed its biogeochemical cycle. Inorganic mercury entering aquatic systems can be transformed into methylmercury, a strong neurotoxicant that builds up in organisms and affects ecosystem and public health. In the Arctic, top predators such as beluga whales, an ecologically and culturally significant species for many Inuit communities, can contain high concentrations of methylmercury.
View Article and Find Full Text PDF